Boston and New YorkBoston and NY

Venture Leaders Biotech 2021

The Venture Leaders program connects the top ten Swiss startups in Biotech to Boston’s world class life sciences ecosystem. Meeting with local experts and investors, the Swiss entrepreneurs immerse themselves in the US market to accelerate their business growth.

Every year, Venturelab selects the 10 best startups in Biotech to participate in an intensive investor roadshow in Boston. Swissnex in Boston partners with the Venture Leaders to provide access to local experts for business feedback as well as mentoring, coaching, and investment.

The Venture Leaders program has been coming to Boston for 16 years and is a much anticipated event in the local ecosystem. Notable alumni include Covagen (acquired by Johnson & Johnson), Redbiotec (partly acquired by Pfizer), KB Medical (acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), and AMAL Therapeutics (acquired by Boehringer Ingelheim)

Interested in meeting any of the Swiss Venture Leaders? Contact Swissnex to learn more.

Program

This program takes place from November 8 – 12, 2021

Monday, November 8

  • Pitch coaching
  • Expert roundtables

Tuesday, November 9

Wednesday – Friday, November 10 – 12

  • Private investor meetings

2021 Biotech Cohort

    Abologix

    Humanized monoclonal antibodies for treatment-resistant cancers. The first target is non-Hodgkins Lymphoma.

    Acthera

    Acthera’s mechano-responsive, Hard-Shelled Liposomes (HSLs) can fill a mission-critical gap for targeted drug release in countless indications, enabling transformative therapeutic approaches and leveraging the potential of available therapies.

    Alithea

    Rapid RNA-seq for blood samples

    Avrion Therapeutics

    Avrion Therapeutics is a spin-off from EPFL developing precision gene therapy solutions to address genetically defined neurological disorders.

    Cellvie

    cellvie is bringing about a new treatment modality, leveraging the therapeutic potential of mitochondria.

    Gnubiotics

    Microbiome therapeutics for human and animal health

    HexagonFab

    On-site protein, antibody and small molecule affinity and kinetic analysis.

    Nemosia

    Tracers for early detection of neurological disorders

    NexImmune

    Novel immunosuppressive therapies for autoimmune-inflammatory diseases and organ transplantation.
1
9

Partners

Venture Leaders in Biotech is an initiative of Venturelab organized by Swissnex in Boston and supported by Vischer Swiss Law and Tax, EPFL, ETH Zurich, and the Canton of Zurich.